Home » TEPNEL COMPLETES ACQUISITION OF GENXTRAK DNA EXTRACTION BUSINESS FROM WHATMAN
TEPNEL COMPLETES ACQUISITION OF GENXTRAK DNA EXTRACTION BUSINESS FROM WHATMAN
The Board of Tepnel Life Sciences PLC has announced the completed acquisition
of the GenXTrak DNA extraction business from UK-based Whatman plc for an undisclosed
sum. The Cambridge-based GenXTrak business will now operate within Tepnel's
service division, offering extraction, purification, quantification and normalisation
of clinical DNA samples.
GenomicsProteomics
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May